Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) Assets Average (2021 - 2025)

Coeptis Therapeutics Holdings (COEP) has 5 years of Assets Average data on record, last reported at $13.2 million in Q3 2025.

  • For Q3 2025, Assets Average rose 100.49% year-over-year to $13.2 million; the TTM value through Sep 2025 reached $13.2 million, up 100.49%, while the annual FY2024 figure was $6.7 million, 7.95% up from the prior year.
  • Assets Average reached $13.2 million in Q3 2025 per COEP's latest filing, up from $12.8 million in the prior quarter.
  • Across five years, Assets Average topped out at $76.5 million in Q2 2021 and bottomed at $4.0 million in Q2 2024.
  • Average Assets Average over 5 years is $23.8 million, with a median of $12.0 million recorded in 2025.
  • Peak YoY movement for Assets Average: plummeted 87.99% in 2023, then skyrocketed 216.88% in 2025.
  • A 5-year view of Assets Average shows it stood at $41.6 million in 2021, then plummeted by 50.42% to $20.6 million in 2022, then crashed by 77.58% to $4.6 million in 2023, then surged by 93.3% to $8.9 million in 2024, then skyrocketed by 47.63% to $13.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets Average were $13.2 million in Q3 2025, $12.8 million in Q2 2025, and $11.2 million in Q1 2025.